FDA-Drug2019-07-17Class II
Losartan Potassium, 100 mg tablets, 90 count bottle, NDC 60429-318-90
Hazard
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
Sold states
US Nationwide One (1) US government account. No foreign accounts.
Affected count
32,835 bottles (2,955,150 tablets)
Manufactured in
5187 Camino Ruiz, Camarillo, CA, United States
Products
Losartan Potassium, 100 mg tablets, 90 count bottle, NDC 60429-318-90
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1465-2019More Golden State Medical Supply Inc. recalls
- FDA-Drug2026-06-17Golden State Medical Supply niacin extended-release tablets recalled for failed dissolution
- FDA-Drug2026-05-27Golden State Medical Supply Primidone Tablets recalled for Acemetacin contamination
- FDA-Drug2026-05-27Golden State Medical Supply Primidone tablets recalled for Acemetacin contamination
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief